Royalties

Saudi Arabia may cut call-termination rates for telecom operators in 2013, the chief executive of Etihad Etisalat (Mobily) told Reuters, in a move that would spur increased competition in the Kingdom....

NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated license agreement with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company, while...

NovaDel Pharma, Inc., a specialty pharmaceutical company, has terminated its license agreements with Talon Therapeutics, Inc. (formerly Hana Biosciences, Inc. ) and Par Pharmaceutical Companies, Inc., for Zensana. Talon is a biopharmaceutical company,...

Greek acquisitions at EFM could be impacted by financial woes in the country. The Greek financial crisis has not left the local film industry unscathed. The 2011 admissions were 10.9m, registering a loss...

XenoPort to Receive $10 Million Milestone Payment TOKYO & SANTA CLARA, Calif. -- Astellas Pharma Inc. (Tokyo:4503) and XenoPort, Inc. (NASDAQ:XNPT) announced today that Regnite([R] ) (gabapentin enacarbil) has received marketing approval in...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee...

BOULDER, Colo. -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that Robert E. Conway has resigned as Chief Executive Officer and a Director for personal reasons. The Board has appointed Kyle Lefkoff, Chairman...

BOGOTA, Colombia -- Fitch Ratings has published a special report titled '2012 Outlook: Local Governments in Colombia'. In the report, Fitch notes the expectation for Stable Outlooks for Fitch rated Local and Regional...

MIDLAND, Texas -- Clayton Williams Energy, Inc. ("CWEI") (NASDAQ:CWEI) today announced that its wholly owned subsidiary, Southwest Royalties, Inc. ("SWR"), has called special meetings of limited partners of each of the 24 limited...

CAMBRIDGE, Mass. -- Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to launch a...

CRANBROOK, British Columbia -- Eagle Plains Resources (TSX-V:EPL)(Pink Sheets: EGPLF) and Providence Resources Corp. (TSX-V: PV) are pleased to announce that a systematic compilation and analysis of historical soil geochemistry data has identified...

EWING, N.J. -- Antares Pharma, Inc. (NYSE Amex: AIS) today announced that it has licensed exclusively its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd.,for marketing in South Korea. Antares will receive undisclosed...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2012. "Rexahn...

Carlsbad-based Isis Pharmaceuticals Inc. said it has entered into agreement with biotechnology giant Biogen Idec of Weston, Mass., to develop and commercialize an investigational drug for a rare genetic disorder known as spinal...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/318c2f/france_pharmaceuti) has announced the addition of the "France Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. Despite the government's focus on fiscal consolidation - which includes...

ALAMINOS CANYON BLOCK 857, Gulf of Mexico - Two hundred miles off the coast of Texas, ribbons of pipe are reaching for oil and natural gas deeper below the ocean s surface than...

Astex's Pyramid[TM] Drug Discovery Collaboration With GSK on Multiple Targets Across Multiple Therapeutics Areas Continues DUBLIN, Calif. -- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) today announced that the multi-year collaboration to discover cancer therapeutics...

SOUTH SAN FRANCISCO, Calif. -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of...

EXTON, Pa. -- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER[R] vaccine to Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; "MTPC") for commercialization...